1. Home
  2. SE vs REGN Comparison

SE vs REGN Comparison

Compare SE & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sea Limited each representing one

SE

Sea Limited each representing one

HOLD

Current Price

$113.43

Market Cap

55.9B

ML Signal

HOLD

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$784.36

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SE
REGN
Founded
2009
1988
Country
Singapore
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.9B
68.8B
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
SE
REGN
Price
$113.43
$784.36
Analyst Decision
Strong Buy
Buy
Analyst Count
10
25
Target Price
$173.69
$830.16
AVG Volume (30 Days)
4.4M
740.3K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
0.55%
EPS Growth
N/A
8.19
EPS
N/A
18.95
Revenue
N/A
$5,872,227,000.00
Revenue This Year
$32.31
$12.45
Revenue Next Year
$21.53
$10.13
P/E Ratio
$49.15
$40.74
Revenue Growth
N/A
20.82
52 Week Low
$77.05
$541.00
52 Week High
$199.30
$821.11

Technical Indicators

Market Signals
Indicator
SE
REGN
Relative Strength Index (RSI) 59.52 78.41
Support Level $103.94 $738.17
Resistance Level $116.91 $783.87
Average True Range (ATR) 3.42 20.59
MACD 0.24 9.66
Stochastic Oscillator 77.25 92.76

Price Performance

Historical Comparison
SE
REGN

About SE Sea Limited each representing one

Sea started as a gaming business, Garena, but in 2015 expanded into e-commerce. Sea operates Southeast Asia's largest e-commerce company, Shopee, in terms of gross merchandise value. Shopee is a hybrid consumer-to-consumer and business-to-consumer marketplace platform operating in Indonesia, Taiwan, Vietnam, Thailand, Malaysia, the Philippines, and Brazil. For Garena, Free Fire is the key revenue-generating game. Sea's third business, Monee, provides lending, payment, digital banking, and insurance services. As of March 2025, Forrest Li, the founder, chair, and CEO, owned 59.1% of the voting power. Tencent owned 18.5% of issued shares with no voting power.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: